1 active not recruiting, 1 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
Follow Neovascularization: new trials by email Literature Review of Neovascularization trials Research Report on Neovascularization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial 4mg/ml KDR2-2 suspension eyedrop, 16mg/ml KDR2-2 suspension eyedrop - Neovascular Glaucoma, Neovascularization | Phase 1 | Active not recruiting | Sun Yat-sen University | 40 | 2021-04-19 | 2024-12-11 |
| Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth Ranibizumab - Neovascularization | Phase 1 | Completed | National Eye Institute (NEI) | 1 | 2008-05-21 | 2017-07-02 |
Neovascularization, Pathologic (2) · Glaucoma, Neovascular (1)
Metaplasia (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Eye Diseases (1) · Glaucoma (1) · Ocular Hypertension (1)
Ranibizumab (1)
National Eye Institute (NEI) (1) · Sun Yat-sen University (1)
China (1) · United States (1)